nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—coronary artery disease—atherosclerosis	0.542	1	CtDrD
Furosemide—ALB—atherosclerosis	0.0776	1	CbGaD
Furosemide—SLC22A11—Pravastatin—atherosclerosis	0.0497	0.18	CbGbCtD
Furosemide—SLC22A5—Niacin—atherosclerosis	0.0457	0.165	CbGbCtD
Furosemide—ABCC2—Ezetimibe—atherosclerosis	0.0302	0.109	CbGbCtD
Furosemide—SLC22A8—Pravastatin—atherosclerosis	0.0289	0.105	CbGbCtD
Furosemide—ABCC2—Simvastatin—atherosclerosis	0.0281	0.102	CbGbCtD
Furosemide—ABCC2—Pravastatin—atherosclerosis	0.0275	0.0995	CbGbCtD
Furosemide—ABCC2—Lovastatin—atherosclerosis	0.0275	0.0995	CbGbCtD
Furosemide—SLC22A6—Pravastatin—atherosclerosis	0.0201	0.0728	CbGbCtD
Furosemide—ALB—Rosuvastatin—atherosclerosis	0.0188	0.0681	CbGbCtD
Furosemide—SLC12A1—appendage—atherosclerosis	0.000543	0.21	CbGeAlD
Furosemide—Cramps of lower extremities—Niacin—atherosclerosis	0.00043	0.00667	CcSEcCtD
Furosemide—Diabetes mellitus—Simvastatin—atherosclerosis	0.000426	0.0066	CcSEcCtD
Furosemide—Urine output increased—Niacin—atherosclerosis	0.000423	0.00656	CcSEcCtD
Furosemide—Photosensitivity—Simvastatin—atherosclerosis	0.000422	0.00654	CcSEcCtD
Furosemide—Swelling—Simvastatin—atherosclerosis	0.00042	0.00651	CcSEcCtD
Furosemide—Vascular purpura—Simvastatin—atherosclerosis	0.000414	0.00642	CcSEcCtD
Furosemide—Muscular weakness—Rosuvastatin—atherosclerosis	0.000412	0.00639	CcSEcCtD
Furosemide—Purpura—Lovastatin—atherosclerosis	0.000411	0.00637	CcSEcCtD
Furosemide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00041	0.00636	CcSEcCtD
Furosemide—Pancreatitis—Rosuvastatin—atherosclerosis	0.000396	0.00614	CcSEcCtD
Furosemide—Diabetes mellitus—Niacin—atherosclerosis	0.000391	0.00606	CcSEcCtD
Furosemide—Polyuria—Niacin—atherosclerosis	0.000387	0.006	CcSEcCtD
Furosemide—Purpura—Simvastatin—atherosclerosis	0.000384	0.00596	CcSEcCtD
Furosemide—Photosensitivity—Pravastatin—atherosclerosis	0.000381	0.00591	CcSEcCtD
Furosemide—Vascular purpura—Pravastatin—atherosclerosis	0.000374	0.0058	CcSEcCtD
Furosemide—Deafness—Pravastatin—atherosclerosis	0.000374	0.0058	CcSEcCtD
Furosemide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000371	0.00575	CcSEcCtD
Furosemide—Cramp muscle—Lovastatin—atherosclerosis	0.000356	0.00553	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000356	0.00553	CcSEcCtD
Furosemide—Dermatitis bullous—Niacin—atherosclerosis	0.000356	0.00551	CcSEcCtD
Furosemide—Cramp muscle—Ezetimibe—atherosclerosis	0.00035	0.00542	CcSEcCtD
Furosemide—Purpura—Pravastatin—atherosclerosis	0.000347	0.00538	CcSEcCtD
Furosemide—Muscular weakness—Ezetimibe—atherosclerosis	0.000342	0.00531	CcSEcCtD
Furosemide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00034	0.00528	CcSEcCtD
Furosemide—Eosinophilia—Lovastatin—atherosclerosis	0.000339	0.00525	CcSEcCtD
Furosemide—Pancreatitis—Lovastatin—atherosclerosis	0.000335	0.0052	CcSEcCtD
Furosemide—Cramp muscle—Simvastatin—atherosclerosis	0.000333	0.00517	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000333	0.00517	CcSEcCtD
Furosemide—Eosinophilia—Ezetimibe—atherosclerosis	0.000332	0.00515	CcSEcCtD
Furosemide—Pancreatitis—Ezetimibe—atherosclerosis	0.000329	0.0051	CcSEcCtD
Furosemide—Muscular weakness—Simvastatin—atherosclerosis	0.000327	0.00506	CcSEcCtD
Furosemide—Urinary retention—Niacin—atherosclerosis	0.000323	0.00501	CcSEcCtD
Furosemide—Eosinophilia—Simvastatin—atherosclerosis	0.000317	0.00491	CcSEcCtD
Furosemide—Pancreatitis—Simvastatin—atherosclerosis	0.000314	0.00486	CcSEcCtD
Furosemide—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000312	0.00484	CcSEcCtD
Furosemide—Orthostatic hypotension—Niacin—atherosclerosis	0.000311	0.00481	CcSEcCtD
Furosemide—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000306	0.00475	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000302	0.00469	CcSEcCtD
Furosemide—Cramp muscle—Pravastatin—atherosclerosis	0.000301	0.00467	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000301	0.00467	CcSEcCtD
Furosemide—Muscular weakness—Niacin—atherosclerosis	0.0003	0.00465	CcSEcCtD
Furosemide—Abdominal distension—Niacin—atherosclerosis	0.000296	0.00459	CcSEcCtD
Furosemide—Muscular weakness—Pravastatin—atherosclerosis	0.000295	0.00458	CcSEcCtD
Furosemide—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000292	0.00453	CcSEcCtD
Furosemide—Abdominal distension—Pravastatin—atherosclerosis	0.000291	0.00452	CcSEcCtD
Furosemide—Arrhythmia—Rosuvastatin—atherosclerosis	0.000289	0.00448	CcSEcCtD
Furosemide—Eosinophilia—Pravastatin—atherosclerosis	0.000286	0.00444	CcSEcCtD
Furosemide—Pancreatitis—Pravastatin—atherosclerosis	0.000284	0.0044	CcSEcCtD
Furosemide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000283	0.00439	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000283	0.00439	CcSEcCtD
Furosemide—Flatulence—Rosuvastatin—atherosclerosis	0.000277	0.0043	CcSEcCtD
Furosemide—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000264	0.00409	CcSEcCtD
Furosemide—Erythema multiforme—Lovastatin—atherosclerosis	0.000259	0.00401	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000256	0.00396	CcSEcCtD
Furosemide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000254	0.00394	CcSEcCtD
Furosemide—Sweating—Niacin—atherosclerosis	0.000251	0.00389	CcSEcCtD
Furosemide—Angiopathy—Ezetimibe—atherosclerosis	0.000244	0.00378	CcSEcCtD
Furosemide—Immune system disorder—Ezetimibe—atherosclerosis	0.000243	0.00376	CcSEcCtD
Furosemide—Erythema multiforme—Simvastatin—atherosclerosis	0.000242	0.00375	CcSEcCtD
Furosemide—Flatulence—Lovastatin—atherosclerosis	0.000235	0.00364	CcSEcCtD
Furosemide—Erythema—Ezetimibe—atherosclerosis	0.000234	0.00362	CcSEcCtD
Furosemide—Malnutrition—Ezetimibe—atherosclerosis	0.000234	0.00362	CcSEcCtD
Furosemide—Dysgeusia—Lovastatin—atherosclerosis	0.000233	0.00362	CcSEcCtD
Furosemide—Confusional state—Rosuvastatin—atherosclerosis	0.000232	0.00359	CcSEcCtD
Furosemide—Flatulence—Ezetimibe—atherosclerosis	0.00023	0.00357	CcSEcCtD
Furosemide—Muscle spasms—Lovastatin—atherosclerosis	0.000229	0.00355	CcSEcCtD
Furosemide—Visual impairment—Niacin—atherosclerosis	0.000227	0.00351	CcSEcCtD
Furosemide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000225	0.00349	CcSEcCtD
Furosemide—Muscle spasms—Ezetimibe—atherosclerosis	0.000225	0.00348	CcSEcCtD
Furosemide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000225	0.00348	CcSEcCtD
Furosemide—Vision blurred—Lovastatin—atherosclerosis	0.000225	0.00348	CcSEcCtD
Furosemide—Visual impairment—Pravastatin—atherosclerosis	0.000223	0.00346	CcSEcCtD
Furosemide—Erythema—Simvastatin—atherosclerosis	0.000223	0.00346	CcSEcCtD
Furosemide—Eye disorder—Niacin—atherosclerosis	0.00022	0.00341	CcSEcCtD
Furosemide—Flatulence—Simvastatin—atherosclerosis	0.00022	0.00341	CcSEcCtD
Furosemide—Tinnitus—Niacin—atherosclerosis	0.000219	0.0034	CcSEcCtD
Furosemide—Erythema multiforme—Pravastatin—atherosclerosis	0.000219	0.00339	CcSEcCtD
Furosemide—Dysgeusia—Simvastatin—atherosclerosis	0.000218	0.00339	CcSEcCtD
Furosemide—Anaemia—Ezetimibe—atherosclerosis	0.000216	0.00335	CcSEcCtD
Furosemide—Tinnitus—Pravastatin—atherosclerosis	0.000216	0.00335	CcSEcCtD
Furosemide—Muscle spasms—Simvastatin—atherosclerosis	0.000214	0.00332	CcSEcCtD
Furosemide—Vertigo—Lovastatin—atherosclerosis	0.000214	0.00332	CcSEcCtD
Furosemide—Angiopathy—Niacin—atherosclerosis	0.000213	0.00331	CcSEcCtD
Furosemide—Leukopenia—Lovastatin—atherosclerosis	0.000213	0.00331	CcSEcCtD
Furosemide—Vision blurred—Simvastatin—atherosclerosis	0.00021	0.00326	CcSEcCtD
Furosemide—Arrhythmia—Niacin—atherosclerosis	0.00021	0.00326	CcSEcCtD
Furosemide—Arrhythmia—Pravastatin—atherosclerosis	0.000207	0.00321	CcSEcCtD
Furosemide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000206	0.0032	CcSEcCtD
Furosemide—Anaemia—Simvastatin—atherosclerosis	0.000206	0.00319	CcSEcCtD
Furosemide—Malnutrition—Niacin—atherosclerosis	0.000205	0.00317	CcSEcCtD
Furosemide—Erythema—Niacin—atherosclerosis	0.000205	0.00317	CcSEcCtD
Furosemide—Flatulence—Niacin—atherosclerosis	0.000202	0.00313	CcSEcCtD
Furosemide—Vertigo—Simvastatin—atherosclerosis	0.0002	0.00311	CcSEcCtD
Furosemide—Leukopenia—Simvastatin—atherosclerosis	0.0002	0.00309	CcSEcCtD
Furosemide—Flatulence—Pravastatin—atherosclerosis	0.000199	0.00308	CcSEcCtD
Furosemide—Dry mouth—Lovastatin—atherosclerosis	0.000199	0.00308	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000198	0.00306	CcSEcCtD
Furosemide—Dysgeusia—Pravastatin—atherosclerosis	0.000197	0.00306	CcSEcCtD
Furosemide—Muscle spasms—Niacin—atherosclerosis	0.000197	0.00305	CcSEcCtD
Furosemide—Pain—Rosuvastatin—atherosclerosis	0.000196	0.00304	CcSEcCtD
Furosemide—Constipation—Rosuvastatin—atherosclerosis	0.000196	0.00304	CcSEcCtD
Furosemide—Confusional state—Lovastatin—atherosclerosis	0.000196	0.00304	CcSEcCtD
Furosemide—Dry mouth—Ezetimibe—atherosclerosis	0.000195	0.00302	CcSEcCtD
Furosemide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000195	0.00302	CcSEcCtD
Furosemide—Muscle spasms—Pravastatin—atherosclerosis	0.000194	0.003	CcSEcCtD
Furosemide—Vision blurred—Niacin—atherosclerosis	0.000193	0.00299	CcSEcCtD
Furosemide—Confusional state—Ezetimibe—atherosclerosis	0.000192	0.00298	CcSEcCtD
Furosemide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000191	0.00296	CcSEcCtD
Furosemide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000191	0.00295	CcSEcCtD
Furosemide—Vision blurred—Pravastatin—atherosclerosis	0.00019	0.00295	CcSEcCtD
Furosemide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000189	0.00293	CcSEcCtD
Furosemide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000188	0.00291	CcSEcCtD
Furosemide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000187	0.0029	CcSEcCtD
Furosemide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000187	0.0029	CcSEcCtD
Furosemide—Anaemia—Pravastatin—atherosclerosis	0.000186	0.00289	CcSEcCtD
Furosemide—Anorexia—Lovastatin—atherosclerosis	0.000185	0.00288	CcSEcCtD
Furosemide—Skin disorder—Ezetimibe—atherosclerosis	0.000185	0.00287	CcSEcCtD
Furosemide—Vertigo—Niacin—atherosclerosis	0.000184	0.00285	CcSEcCtD
Furosemide—Confusional state—Simvastatin—atherosclerosis	0.000184	0.00284	CcSEcCtD
Furosemide—Leukopenia—Niacin—atherosclerosis	0.000183	0.00284	CcSEcCtD
Furosemide—Urticaria—Rosuvastatin—atherosclerosis	0.000182	0.00283	CcSEcCtD
Furosemide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000182	0.00282	CcSEcCtD
Furosemide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000181	0.00281	CcSEcCtD
Furosemide—Vertigo—Pravastatin—atherosclerosis	0.000181	0.00281	CcSEcCtD
Furosemide—Leukopenia—Pravastatin—atherosclerosis	0.00018	0.0028	CcSEcCtD
Furosemide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000178	0.00276	CcSEcCtD
Furosemide—Paraesthesia—Lovastatin—atherosclerosis	0.000175	0.00271	CcSEcCtD
Furosemide—Anorexia—Simvastatin—atherosclerosis	0.000173	0.00269	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000173	0.00268	CcSEcCtD
Furosemide—Paraesthesia—Ezetimibe—atherosclerosis	0.000171	0.00266	CcSEcCtD
Furosemide—Dry mouth—Niacin—atherosclerosis	0.00017	0.00264	CcSEcCtD
Furosemide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000169	0.00262	CcSEcCtD
Furosemide—Decreased appetite—Lovastatin—atherosclerosis	0.000169	0.00262	CcSEcCtD
Furosemide—Fatigue—Lovastatin—atherosclerosis	0.000168	0.0026	CcSEcCtD
Furosemide—CA5A—liver—atherosclerosis	0.000168	0.0648	CbGeAlD
Furosemide—Anaphylactic shock—Niacin—atherosclerosis	0.000167	0.00259	CcSEcCtD
Furosemide—Constipation—Lovastatin—atherosclerosis	0.000166	0.00258	CcSEcCtD
Furosemide—Pain—Lovastatin—atherosclerosis	0.000166	0.00258	CcSEcCtD
Furosemide—Confusional state—Pravastatin—atherosclerosis	0.000166	0.00257	CcSEcCtD
Furosemide—Decreased appetite—Ezetimibe—atherosclerosis	0.000166	0.00257	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000165	0.00255	CcSEcCtD
Furosemide—Asthenia—Rosuvastatin—atherosclerosis	0.000165	0.00255	CcSEcCtD
Furosemide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000165	0.00255	CcSEcCtD
Furosemide—Fatigue—Ezetimibe—atherosclerosis	0.000165	0.00255	CcSEcCtD
Furosemide—Shock—Niacin—atherosclerosis	0.000164	0.00255	CcSEcCtD
Furosemide—Paraesthesia—Simvastatin—atherosclerosis	0.000163	0.00253	CcSEcCtD
Furosemide—Constipation—Ezetimibe—atherosclerosis	0.000163	0.00253	CcSEcCtD
Furosemide—Pain—Ezetimibe—atherosclerosis	0.000163	0.00253	CcSEcCtD
Furosemide—Pruritus—Rosuvastatin—atherosclerosis	0.000162	0.00252	CcSEcCtD
Furosemide—Skin disorder—Niacin—atherosclerosis	0.000162	0.00252	CcSEcCtD
Furosemide—Hyperhidrosis—Niacin—atherosclerosis	0.000162	0.0025	CcSEcCtD
Furosemide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000161	0.0025	CcSEcCtD
Furosemide—Feeling abnormal—Lovastatin—atherosclerosis	0.00016	0.00249	CcSEcCtD
Furosemide—Anorexia—Niacin—atherosclerosis	0.000159	0.00247	CcSEcCtD
Furosemide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000159	0.00247	CcSEcCtD
Furosemide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000159	0.00247	CcSEcCtD
Furosemide—Decreased appetite—Simvastatin—atherosclerosis	0.000158	0.00245	CcSEcCtD
Furosemide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000157	0.00244	CcSEcCtD
Furosemide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000157	0.00244	CcSEcCtD
Furosemide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000157	0.00244	CcSEcCtD
Furosemide—Fatigue—Simvastatin—atherosclerosis	0.000157	0.00243	CcSEcCtD
Furosemide—Anorexia—Pravastatin—atherosclerosis	0.000157	0.00243	CcSEcCtD
Furosemide—Hypotension—Niacin—atherosclerosis	0.000156	0.00242	CcSEcCtD
Furosemide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000156	0.00242	CcSEcCtD
Furosemide—Constipation—Simvastatin—atherosclerosis	0.000156	0.00241	CcSEcCtD
Furosemide—Pain—Simvastatin—atherosclerosis	0.000156	0.00241	CcSEcCtD
Furosemide—Urticaria—Lovastatin—atherosclerosis	0.000155	0.0024	CcSEcCtD
Furosemide—Abdominal pain—Lovastatin—atherosclerosis	0.000154	0.00238	CcSEcCtD
Furosemide—Body temperature increased—Lovastatin—atherosclerosis	0.000154	0.00238	CcSEcCtD
Furosemide—Dizziness—Rosuvastatin—atherosclerosis	0.000152	0.00235	CcSEcCtD
Furosemide—Urticaria—Ezetimibe—atherosclerosis	0.000152	0.00235	CcSEcCtD
Furosemide—Body temperature increased—Ezetimibe—atherosclerosis	0.000151	0.00234	CcSEcCtD
Furosemide—Abdominal pain—Ezetimibe—atherosclerosis	0.000151	0.00234	CcSEcCtD
Furosemide—Paraesthesia—Niacin—atherosclerosis	0.00015	0.00233	CcSEcCtD
Furosemide—Feeling abnormal—Simvastatin—atherosclerosis	0.00015	0.00232	CcSEcCtD
Furosemide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000149	0.00231	CcSEcCtD
Furosemide—Somnolence—Niacin—atherosclerosis	0.000149	0.0023	CcSEcCtD
Furosemide—Paraesthesia—Pravastatin—atherosclerosis	0.000148	0.00229	CcSEcCtD
Furosemide—Decreased appetite—Niacin—atherosclerosis	0.000145	0.00225	CcSEcCtD
Furosemide—Rash—Rosuvastatin—atherosclerosis	0.000145	0.00224	CcSEcCtD
Furosemide—Dermatitis—Rosuvastatin—atherosclerosis	0.000145	0.00224	CcSEcCtD
Furosemide—Urticaria—Simvastatin—atherosclerosis	0.000145	0.00224	CcSEcCtD
Furosemide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000144	0.00224	CcSEcCtD
Furosemide—Body temperature increased—Simvastatin—atherosclerosis	0.000144	0.00223	CcSEcCtD
Furosemide—Abdominal pain—Simvastatin—atherosclerosis	0.000144	0.00223	CcSEcCtD
Furosemide—Headache—Rosuvastatin—atherosclerosis	0.000144	0.00223	CcSEcCtD
Furosemide—Hypersensitivity—Lovastatin—atherosclerosis	0.000143	0.00222	CcSEcCtD
Furosemide—Decreased appetite—Pravastatin—atherosclerosis	0.000143	0.00222	CcSEcCtD
Furosemide—Pain—Niacin—atherosclerosis	0.000143	0.00222	CcSEcCtD
Furosemide—Fatigue—Pravastatin—atherosclerosis	0.000142	0.0022	CcSEcCtD
Furosemide—Pain—Pravastatin—atherosclerosis	0.000141	0.00218	CcSEcCtD
Furosemide—Constipation—Pravastatin—atherosclerosis	0.000141	0.00218	CcSEcCtD
Furosemide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000141	0.00218	CcSEcCtD
Furosemide—Asthenia—Lovastatin—atherosclerosis	0.00014	0.00216	CcSEcCtD
Furosemide—Pruritus—Lovastatin—atherosclerosis	0.000138	0.00213	CcSEcCtD
Furosemide—Asthenia—Ezetimibe—atherosclerosis	0.000137	0.00212	CcSEcCtD
Furosemide—Gastrointestinal pain—Niacin—atherosclerosis	0.000137	0.00212	CcSEcCtD
Furosemide—Nausea—Rosuvastatin—atherosclerosis	0.000136	0.00211	CcSEcCtD
Furosemide—Feeling abnormal—Pravastatin—atherosclerosis	0.000136	0.0021	CcSEcCtD
Furosemide—Pruritus—Ezetimibe—atherosclerosis	0.000135	0.00209	CcSEcCtD
Furosemide—CA12—connective tissue—atherosclerosis	0.000135	0.052	CbGeAlD
Furosemide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000135	0.00209	CcSEcCtD
Furosemide—Hypersensitivity—Simvastatin—atherosclerosis	0.000134	0.00208	CcSEcCtD
Furosemide—Diarrhoea—Lovastatin—atherosclerosis	0.000133	0.00206	CcSEcCtD
Furosemide—Urticaria—Niacin—atherosclerosis	0.000133	0.00206	CcSEcCtD
Furosemide—Abdominal pain—Niacin—atherosclerosis	0.000132	0.00205	CcSEcCtD
Furosemide—Body temperature increased—Niacin—atherosclerosis	0.000132	0.00205	CcSEcCtD
Furosemide—Urticaria—Pravastatin—atherosclerosis	0.000131	0.00203	CcSEcCtD
Furosemide—Asthenia—Simvastatin—atherosclerosis	0.000131	0.00202	CcSEcCtD
Furosemide—Diarrhoea—Ezetimibe—atherosclerosis	0.000131	0.00202	CcSEcCtD
Furosemide—Abdominal pain—Pravastatin—atherosclerosis	0.00013	0.00202	CcSEcCtD
Furosemide—Body temperature increased—Pravastatin—atherosclerosis	0.00013	0.00202	CcSEcCtD
Furosemide—Pruritus—Simvastatin—atherosclerosis	0.000129	0.002	CcSEcCtD
Furosemide—Dizziness—Lovastatin—atherosclerosis	0.000129	0.00199	CcSEcCtD
Furosemide—PGD—connective tissue—atherosclerosis	0.000128	0.0493	CbGeAlD
Furosemide—Dizziness—Ezetimibe—atherosclerosis	0.000126	0.00196	CcSEcCtD
Furosemide—Diarrhoea—Simvastatin—atherosclerosis	0.000125	0.00193	CcSEcCtD
Furosemide—Vomiting—Lovastatin—atherosclerosis	0.000124	0.00192	CcSEcCtD
Furosemide—Hypersensitivity—Niacin—atherosclerosis	0.000123	0.00191	CcSEcCtD
Furosemide—Rash—Lovastatin—atherosclerosis	0.000123	0.0019	CcSEcCtD
Furosemide—Dermatitis—Lovastatin—atherosclerosis	0.000123	0.0019	CcSEcCtD
Furosemide—Headache—Lovastatin—atherosclerosis	0.000122	0.00189	CcSEcCtD
Furosemide—Vomiting—Ezetimibe—atherosclerosis	0.000121	0.00188	CcSEcCtD
Furosemide—Hypersensitivity—Pravastatin—atherosclerosis	0.000121	0.00188	CcSEcCtD
Furosemide—Dizziness—Simvastatin—atherosclerosis	0.00012	0.00187	CcSEcCtD
Furosemide—Rash—Ezetimibe—atherosclerosis	0.00012	0.00187	CcSEcCtD
Furosemide—Dermatitis—Ezetimibe—atherosclerosis	0.00012	0.00186	CcSEcCtD
Furosemide—Asthenia—Niacin—atherosclerosis	0.00012	0.00186	CcSEcCtD
Furosemide—Headache—Ezetimibe—atherosclerosis	0.00012	0.00185	CcSEcCtD
Furosemide—Pruritus—Niacin—atherosclerosis	0.000118	0.00183	CcSEcCtD
Furosemide—Asthenia—Pravastatin—atherosclerosis	0.000118	0.00183	CcSEcCtD
Furosemide—Pruritus—Pravastatin—atherosclerosis	0.000116	0.0018	CcSEcCtD
Furosemide—Vomiting—Simvastatin—atherosclerosis	0.000116	0.00179	CcSEcCtD
Furosemide—Nausea—Lovastatin—atherosclerosis	0.000116	0.00179	CcSEcCtD
Furosemide—Rash—Simvastatin—atherosclerosis	0.000115	0.00178	CcSEcCtD
Furosemide—Dermatitis—Simvastatin—atherosclerosis	0.000115	0.00178	CcSEcCtD
Furosemide—Diarrhoea—Niacin—atherosclerosis	0.000114	0.00177	CcSEcCtD
Furosemide—Headache—Simvastatin—atherosclerosis	0.000114	0.00177	CcSEcCtD
Furosemide—Nausea—Ezetimibe—atherosclerosis	0.000113	0.00176	CcSEcCtD
Furosemide—Diarrhoea—Pravastatin—atherosclerosis	0.000113	0.00175	CcSEcCtD
Furosemide—PGD—cardiovascular system—atherosclerosis	0.000111	0.0429	CbGeAlD
Furosemide—Dizziness—Niacin—atherosclerosis	0.000111	0.00171	CcSEcCtD
Furosemide—SLCO2A1—adipose tissue—atherosclerosis	0.00011	0.0424	CbGeAlD
Furosemide—Dizziness—Pravastatin—atherosclerosis	0.000109	0.00169	CcSEcCtD
Furosemide—Nausea—Simvastatin—atherosclerosis	0.000108	0.00168	CcSEcCtD
Furosemide—Vomiting—Niacin—atherosclerosis	0.000106	0.00165	CcSEcCtD
Furosemide—Rash—Niacin—atherosclerosis	0.000105	0.00163	CcSEcCtD
Furosemide—Dermatitis—Niacin—atherosclerosis	0.000105	0.00163	CcSEcCtD
Furosemide—CA5B—cardiovascular system—atherosclerosis	0.000105	0.0406	CbGeAlD
Furosemide—Headache—Niacin—atherosclerosis	0.000105	0.00162	CcSEcCtD
Furosemide—Vomiting—Pravastatin—atherosclerosis	0.000105	0.00162	CcSEcCtD
Furosemide—Rash—Pravastatin—atherosclerosis	0.000104	0.00161	CcSEcCtD
Furosemide—Dermatitis—Pravastatin—atherosclerosis	0.000104	0.00161	CcSEcCtD
Furosemide—Headache—Pravastatin—atherosclerosis	0.000103	0.0016	CcSEcCtD
Furosemide—Nausea—Niacin—atherosclerosis	9.93e-05	0.00154	CcSEcCtD
Furosemide—PGD—adipose tissue—atherosclerosis	9.79e-05	0.0378	CbGeAlD
Furosemide—Nausea—Pravastatin—atherosclerosis	9.77e-05	0.00152	CcSEcCtD
Furosemide—CA14—liver—atherosclerosis	9.3e-05	0.0359	CbGeAlD
Furosemide—CA1—cardiovascular system—atherosclerosis	9.29e-05	0.0359	CbGeAlD
Furosemide—CA5B—adipose tissue—atherosclerosis	9.27e-05	0.0358	CbGeAlD
Furosemide—SLC22A11—liver—atherosclerosis	8.59e-05	0.0332	CbGeAlD
Furosemide—CA1—adipose tissue—atherosclerosis	8.19e-05	0.0316	CbGeAlD
Furosemide—SLCO2A1—liver—atherosclerosis	7.7e-05	0.0297	CbGeAlD
Furosemide—CA4—cardiovascular system—atherosclerosis	7.26e-05	0.028	CbGeAlD
Furosemide—CA2—connective tissue—atherosclerosis	6.92e-05	0.0267	CbGeAlD
Furosemide—PGD—liver—atherosclerosis	6.87e-05	0.0265	CbGeAlD
Furosemide—CA4—adipose tissue—atherosclerosis	6.4e-05	0.0247	CbGeAlD
Furosemide—CA2—cardiovascular system—atherosclerosis	6.02e-05	0.0232	CbGeAlD
Furosemide—CA1—liver—atherosclerosis	5.74e-05	0.0222	CbGeAlD
Furosemide—CA2—adipose tissue—atherosclerosis	5.31e-05	0.0205	CbGeAlD
Furosemide—SLC22A5—adipose tissue—atherosclerosis	5.22e-05	0.0202	CbGeAlD
Furosemide—ALB—liver—atherosclerosis	5.04e-05	0.0195	CbGeAlD
Furosemide—ABCC2—liver—atherosclerosis	4.73e-05	0.0182	CbGeAlD
Furosemide—CA2—liver—atherosclerosis	3.72e-05	0.0144	CbGeAlD
Furosemide—SLC22A5—liver—atherosclerosis	3.66e-05	0.0141	CbGeAlD
Furosemide—CA5A—Metabolism—PPARG—atherosclerosis	1.19e-05	0.000324	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CG—atherosclerosis	1.19e-05	0.000323	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	1.19e-05	0.000323	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—atherosclerosis	1.18e-05	0.000321	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOB—atherosclerosis	1.18e-05	0.000321	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—atherosclerosis	1.18e-05	0.000321	CbGpPWpGaD
Furosemide—PGD—Disease—NOS3—atherosclerosis	1.18e-05	0.000321	CbGpPWpGaD
Furosemide—CA2—Metabolism—HMOX1—atherosclerosis	1.18e-05	0.00032	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOB—atherosclerosis	1.18e-05	0.00032	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAV1—atherosclerosis	1.17e-05	0.000318	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.17e-05	0.000318	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOA1—atherosclerosis	1.17e-05	0.000318	CbGpPWpGaD
Furosemide—CA6—Metabolism—INS—atherosclerosis	1.17e-05	0.000317	CbGpPWpGaD
Furosemide—CA5A—Metabolism—INS—atherosclerosis	1.17e-05	0.000317	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCA1—atherosclerosis	1.16e-05	0.000315	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.15e-05	0.000314	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CG—atherosclerosis	1.15e-05	0.000313	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CG—atherosclerosis	1.15e-05	0.000313	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—atherosclerosis	1.15e-05	0.000312	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTM1—atherosclerosis	1.14e-05	0.000311	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VWF—atherosclerosis	1.14e-05	0.000311	CbGpPWpGaD
Furosemide—CA1—Metabolism—HMOX1—atherosclerosis	1.13e-05	0.000307	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOB—atherosclerosis	1.13e-05	0.000307	CbGpPWpGaD
Furosemide—PGD—Metabolism—INS—atherosclerosis	1.13e-05	0.000306	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLTP—atherosclerosis	1.12e-05	0.000306	CbGpPWpGaD
Furosemide—CA4—Metabolism—LPL—atherosclerosis	1.12e-05	0.000306	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	1.12e-05	0.000305	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—atherosclerosis	1.11e-05	0.000303	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—atherosclerosis	1.11e-05	0.000302	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—atherosclerosis	1.11e-05	0.000302	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—atherosclerosis	1.1e-05	0.000299	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTM1—atherosclerosis	1.1e-05	0.000299	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	1.1e-05	0.000299	CbGpPWpGaD
Furosemide—CA4—Metabolism—GPX1—atherosclerosis	1.1e-05	0.000298	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F7—atherosclerosis	1.09e-05	0.000297	CbGpPWpGaD
Furosemide—CA5B—Metabolism—INS—atherosclerosis	1.09e-05	0.000296	CbGpPWpGaD
Furosemide—CA7—Metabolism—INS—atherosclerosis	1.09e-05	0.000296	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOB—atherosclerosis	1.08e-05	0.000294	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—atherosclerosis	1.08e-05	0.000293	CbGpPWpGaD
Furosemide—CA2—Metabolism—LPL—atherosclerosis	1.08e-05	0.000293	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	1.07e-05	0.000291	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—atherosclerosis	1.07e-05	0.000291	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—atherosclerosis	1.07e-05	0.000291	CbGpPWpGaD
Furosemide—CA4—Metabolism—CD36—atherosclerosis	1.07e-05	0.00029	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CG—atherosclerosis	1.07e-05	0.00029	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTM1—atherosclerosis	1.05e-05	0.000286	CbGpPWpGaD
Furosemide—CA2—Metabolism—GPX1—atherosclerosis	1.05e-05	0.000286	CbGpPWpGaD
Furosemide—CA14—Metabolism—NOS3—atherosclerosis	1.05e-05	0.000286	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.04e-05	0.000283	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.04e-05	0.000282	CbGpPWpGaD
Furosemide—CA1—Metabolism—LPL—atherosclerosis	1.03e-05	0.000281	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—atherosclerosis	1.03e-05	0.000281	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.03e-05	0.00028	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—atherosclerosis	1.03e-05	0.00028	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.03e-05	0.000279	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	1.02e-05	0.000279	CbGpPWpGaD
Furosemide—CA2—Metabolism—CD36—atherosclerosis	1.02e-05	0.000278	CbGpPWpGaD
Furosemide—CA6—Metabolism—NOS3—atherosclerosis	1.02e-05	0.000278	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NOS3—atherosclerosis	1.02e-05	0.000278	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTHFR—atherosclerosis	1.01e-05	0.000275	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—atherosclerosis	1.01e-05	0.000275	CbGpPWpGaD
Furosemide—CA12—Metabolism—INS—atherosclerosis	1.01e-05	0.000275	CbGpPWpGaD
Furosemide—CA1—Metabolism—GPX1—atherosclerosis	1.01e-05	0.000274	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.01e-05	0.000273	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—atherosclerosis	9.98e-06	0.000272	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—atherosclerosis	9.98e-06	0.000272	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.95e-06	0.000271	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—atherosclerosis	9.93e-06	0.00027	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARA—atherosclerosis	9.93e-06	0.00027	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—atherosclerosis	9.87e-06	0.000269	CbGpPWpGaD
Furosemide—CA1—Metabolism—CD36—atherosclerosis	9.81e-06	0.000267	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG8—atherosclerosis	9.75e-06	0.000265	CbGpPWpGaD
Furosemide—ALB—Metabolism—LTA4H—atherosclerosis	9.75e-06	0.000265	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAT—atherosclerosis	9.73e-06	0.000265	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTHFR—atherosclerosis	9.7e-06	0.000264	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	9.64e-06	0.000262	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	9.63e-06	0.000262	CbGpPWpGaD
Furosemide—CA4—Metabolism—AGT—atherosclerosis	9.61e-06	0.000262	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—atherosclerosis	9.6e-06	0.000261	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	9.56e-06	0.00026	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—atherosclerosis	9.55e-06	0.00026	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—atherosclerosis	9.55e-06	0.00026	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARA—atherosclerosis	9.52e-06	0.000259	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOB—atherosclerosis	9.51e-06	0.000259	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—atherosclerosis	9.42e-06	0.000256	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	9.38e-06	0.000255	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—atherosclerosis	9.36e-06	0.000255	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—atherosclerosis	9.36e-06	0.000255	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—APOA1—atherosclerosis	9.33e-06	0.000254	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAV1—atherosclerosis	9.33e-06	0.000254	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOA1—atherosclerosis	9.31e-06	0.000253	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTHFR—atherosclerosis	9.3e-06	0.000253	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—atherosclerosis	9.25e-06	0.000252	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—atherosclerosis	9.25e-06	0.000252	CbGpPWpGaD
Furosemide—CA2—Metabolism—AGT—atherosclerosis	9.22e-06	0.000251	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	9.15e-06	0.000249	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARA—atherosclerosis	9.12e-06	0.000248	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	9.09e-06	0.000247	CbGpPWpGaD
Furosemide—CA9—Metabolism—LPL—atherosclerosis	9.08e-06	0.000247	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—atherosclerosis	9.03e-06	0.000246	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—atherosclerosis	9.03e-06	0.000246	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAV1—atherosclerosis	8.95e-06	0.000243	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOA1—atherosclerosis	8.93e-06	0.000243	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	8.91e-06	0.000242	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—atherosclerosis	8.86e-06	0.000241	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	8.86e-06	0.000241	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—atherosclerosis	8.85e-06	0.000241	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—atherosclerosis	8.84e-06	0.00024	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—atherosclerosis	8.74e-06	0.000238	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—atherosclerosis	8.74e-06	0.000238	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—atherosclerosis	8.66e-06	0.000236	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—atherosclerosis	8.63e-06	0.000235	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAV1—atherosclerosis	8.58e-06	0.000233	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—atherosclerosis	8.56e-06	0.000233	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KNG1—atherosclerosis	8.54e-06	0.000232	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—atherosclerosis	8.5e-06	0.000231	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAUR—atherosclerosis	8.47e-06	0.00023	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	8.42e-06	0.000229	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—atherosclerosis	8.41e-06	0.000229	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLG—atherosclerosis	8.27e-06	0.000225	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—atherosclerosis	8.2e-06	0.000223	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—atherosclerosis	8.17e-06	0.000222	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—atherosclerosis	8.15e-06	0.000222	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.1e-06	0.00022	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—atherosclerosis	8.09e-06	0.00022	CbGpPWpGaD
Furosemide—CA4—Metabolism—INS—atherosclerosis	8.05e-06	0.000219	CbGpPWpGaD
Furosemide—PGD—Disease—MAPK3—atherosclerosis	8.03e-06	0.000219	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARA—atherosclerosis	8.02e-06	0.000218	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—atherosclerosis	7.93e-06	0.000216	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—atherosclerosis	7.87e-06	0.000214	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—atherosclerosis	7.81e-06	0.000213	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—atherosclerosis	7.79e-06	0.000212	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—atherosclerosis	7.77e-06	0.000211	CbGpPWpGaD
Furosemide—CA2—Metabolism—INS—atherosclerosis	7.71e-06	0.00021	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG1—atherosclerosis	7.71e-06	0.00021	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	7.64e-06	0.000208	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—atherosclerosis	7.61e-06	0.000207	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAV1—atherosclerosis	7.54e-06	0.000205	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—atherosclerosis	7.54e-06	0.000205	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—atherosclerosis	7.53e-06	0.000205	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—atherosclerosis	7.52e-06	0.000205	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	7.4e-06	0.000201	CbGpPWpGaD
Furosemide—CA1—Metabolism—INS—atherosclerosis	7.4e-06	0.000201	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—atherosclerosis	7.38e-06	0.000201	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOB—atherosclerosis	7.31e-06	0.000199	CbGpPWpGaD
Furosemide—ALB—Metabolism—LCAT—atherosclerosis	7.25e-06	0.000197	CbGpPWpGaD
Furosemide—ALB—Metabolism—FABP4—atherosclerosis	7.25e-06	0.000197	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	7.16e-06	0.000195	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA4—atherosclerosis	7.11e-06	0.000194	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—atherosclerosis	7.07e-06	0.000192	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—atherosclerosis	7.06e-06	0.000192	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP7A1—atherosclerosis	6.99e-06	0.00019	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—atherosclerosis	6.87e-06	0.000187	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCG—atherosclerosis	6.79e-06	0.000185	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—atherosclerosis	6.78e-06	0.000184	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—atherosclerosis	6.76e-06	0.000184	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.66e-06	0.000181	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—atherosclerosis	6.64e-06	0.000181	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—atherosclerosis	6.63e-06	0.00018	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.61e-06	0.00018	CbGpPWpGaD
Furosemide—CA9—Metabolism—INS—atherosclerosis	6.5e-06	0.000177	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—atherosclerosis	6.49e-06	0.000176	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP27A1—atherosclerosis	6.46e-06	0.000176	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—atherosclerosis	6.45e-06	0.000176	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.36e-06	0.000173	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	6.33e-06	0.000172	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.2e-06	0.000169	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—atherosclerosis	6.19e-06	0.000168	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	6.13e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G2A—atherosclerosis	6.12e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA2—atherosclerosis	6.12e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALOX15—atherosclerosis	6.12e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALOX5AP—atherosclerosis	6.12e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PDGFB—atherosclerosis	6.12e-06	0.000167	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—atherosclerosis	6.05e-06	0.000165	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCG5—atherosclerosis	6.05e-06	0.000165	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.04e-06	0.000164	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—atherosclerosis	5.96e-06	0.000162	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—atherosclerosis	5.93e-06	0.000161	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—atherosclerosis	5.87e-06	0.00016	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPA—atherosclerosis	5.84e-06	0.000159	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAV1—atherosclerosis	5.8e-06	0.000158	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	5.8e-06	0.000158	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—atherosclerosis	5.79e-06	0.000157	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—atherosclerosis	5.7e-06	0.000155	CbGpPWpGaD
Furosemide—ALB—Metabolism—BGN—atherosclerosis	5.66e-06	0.000154	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	5.63e-06	0.000153	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.62e-06	0.000153	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA5—atherosclerosis	5.6e-06	0.000152	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2—atherosclerosis	5.52e-06	0.00015	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—atherosclerosis	5.45e-06	0.000148	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.44e-06	0.000148	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—atherosclerosis	5.42e-06	0.000147	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G1B—atherosclerosis	5.39e-06	0.000147	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.34e-06	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.33e-06	0.000145	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—atherosclerosis	5.28e-06	0.000144	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.28e-06	0.000144	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.27e-06	0.000143	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—atherosclerosis	5.21e-06	0.000142	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALOX5—atherosclerosis	5.21e-06	0.000142	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.01e-06	0.000136	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—atherosclerosis	4.84e-06	0.000132	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—atherosclerosis	4.83e-06	0.000131	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.81e-06	0.000131	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—atherosclerosis	4.7e-06	0.000128	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—atherosclerosis	4.7e-06	0.000128	CbGpPWpGaD
Furosemide—ALB—Metabolism—NAMPT—atherosclerosis	4.67e-06	0.000127	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.64e-06	0.000126	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—atherosclerosis	4.64e-06	0.000126	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOC3—atherosclerosis	4.61e-06	0.000125	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—atherosclerosis	4.59e-06	0.000125	CbGpPWpGaD
Furosemide—ALB—Metabolism—LDLR—atherosclerosis	4.58e-06	0.000125	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—atherosclerosis	4.54e-06	0.000123	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—atherosclerosis	4.48e-06	0.000122	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—atherosclerosis	4.39e-06	0.000119	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—atherosclerosis	4.39e-06	0.000119	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—atherosclerosis	4.39e-06	0.000119	CbGpPWpGaD
Furosemide—ALB—Metabolism—SCARB1—atherosclerosis	4.29e-06	0.000117	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—atherosclerosis	4.07e-06	0.000111	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMGCR—atherosclerosis	4.05e-06	0.00011	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	3.91e-06	0.000106	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.65e-06	9.93e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCA1—atherosclerosis	3.61e-06	9.82e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—atherosclerosis	3.24e-06	8.82e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—atherosclerosis	3.16e-06	8.6e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—atherosclerosis	3.11e-06	8.46e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—atherosclerosis	3.1e-06	8.42e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MAPK3—atherosclerosis	2.99e-06	8.13e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—atherosclerosis	2.98e-06	8.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOB—atherosclerosis	2.97e-06	8.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—atherosclerosis	2.9e-06	7.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—atherosclerosis	2.88e-06	7.85e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—atherosclerosis	2.83e-06	7.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—atherosclerosis	2.76e-06	7.52e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—atherosclerosis	2.69e-06	7.32e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—atherosclerosis	2.62e-06	7.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—atherosclerosis	2.55e-06	6.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARA—atherosclerosis	2.5e-06	6.8e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—atherosclerosis	2.42e-06	6.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—atherosclerosis	2.37e-06	6.46e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAV1—atherosclerosis	2.35e-06	6.4e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—atherosclerosis	2.35e-06	6.38e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—atherosclerosis	2.14e-06	5.83e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—atherosclerosis	2.07e-06	5.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INS—atherosclerosis	2.03e-06	5.52e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—atherosclerosis	2.02e-06	5.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—atherosclerosis	1.78e-06	4.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—atherosclerosis	1.63e-06	4.42e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—atherosclerosis	8.17e-07	2.22e-05	CbGpPWpGaD
